Alternatives to Latvia – Education and training services – Skaistumkopšanas kursu nodrošināšana jauniešiem projektā “PROTI un DARI 2.0"

Nottinghamshire County Council is seeking to establish a Provider List, using a Framework under the Light Touch regime of the Procurement Act 2023, of organisations who are able to provide commissioned placements of children and young people with Alternative education (Provider). These services will cover the requirements for Alternative Provision placements of children & young people (Learners) made directly on behalf of Nottinghamshire County Council with, subject to internal governance approval and compliance with the Procurement Act 2023, additional scope to include Local Council maintained Schools, or Free Schools and Academies (Contracting Council) within Nottinghamshire and surrounding areas if they wish to use it. Providers that are successful in demonstrating that they are able to meet the Council's standards, as set out in the service specification, will be added to the Provider List and will be awarded onto the Framework under the appropriate Lot and will be subsequently invited to offer places that match the needs of the Learners. Providers will be expected to evidence the quality of their provision by participating in regular Quality Assurance (QA) checks that will be carried out on behalf of the Contracting Authorities. Any Providers that fail to maintain the quality standards will be suspended from the Framework until they are able to provide evidence that they can meet the quality standards. Please note, there is no guarantee of work under Lots 2,3 and 4 of this Framework.

France – Education and training services – Marché relatif à la conception et à l'animation d'actions de formation pour le CAMPUS ACTEE de la SASU FNCCR - Année 2026

NCS are requesting tenders from suppliers interested in working in partnership across a number of subcontract delivery contracts within the radius of Swindon for up to £2.67m gross income over the 2026/27 academic year, with the intended outcome of selecting the most advantageous tender(s) (MAT) to deliver a fixed-term contract from 01 August 2026 to 31 July 2027. Spend details are indicative only, award of funding is subject to the criteria detailed within this Guidance, and NCS reserve the right to make multiple awards where best value can be achieved and in accordance with NCS subcontract strategy. The tender has been split into the following requirements: 1. Adult Skills Fund (ASF) Programmes (Level 2 and upwards) 2. Adult Skills Fund (ASF) Tailored Learning (any level) 3. Apprenticeships (Level 2 and upwards) 4. 16-18 Provision (Level 3 and upwards - consideration will be given to Level 2) 5. Higher Education (Level 3 and upwards) Face to face and distance learning offers will be considered however all learners must reside within 60 miles of Swindon. Tenderer's are invited to apply for one or all Lots in accordance with their own technical capability and capacity. Includes Lots: Lot 1: Lot 1 Lot 2: Lot 2 Lot 3: Lot 3 Lot 4: Lot 4 Lot 5: Lot 5 To access this competition: Registered: Login to https://suppliers.multiquote.com and view the opportunity CA17886. Not registered: Visit https://suppliers.multiquote.com then register and quote CA17886 as the reason for registration. Any queries please contact MultiQuote on 020 3920 8054.

Italy – Pre-school education services – STAZIONE UNICA APPALTANTE PROVINCIA DI BERGAMO. COMUNE DI GORLE (BG). SERVIZIO DI GESTIONE DEL NIDO D'INFANZIA COMUNALE "GIANNI RODARI" DEL COMUNE DI GORLE (BG). PERIODO 01/08/2026 - 31/07/2031 (5 ANNI).

Italy – Staff training services – Servizio di realizzazione ed erogazione di interventi di formazione per il personale di RAP S.p.A.

Spain – Education and training services – Gestión de la escuela municipal de música Musikaia.

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites applications for projects to expand, improve, or transform the utility of mammalian cancer and tumor models for translational research. With this NOFO, the NCI intends to encourage submission of projects devoted to demonstrating that mammalian models or their derivatives used for translational research are robust representations of human biology, are appropriate to test questions of clinical importance, and provide reliable information for patients' benefit. These practical goals contrast with the goals of many mechanistic, NCI-supported R01 projects that employ mammals, or develop and use mammalian cancer models, transplantation tumor models, or models derived from mammalian or human tissues or cells for hypothesis-testing, non-clinical research. Among many other possible endeavors, applicants in response to this FOA could propose demonstrations of how to overcome translational deficiencies of mammalian oncology models, define new uses of mammalian models or their genetics for unexplored translational challenges, advance standard practices for use of translational models, test approaches to validate and credential models, or challenge current practices for how models are used translationally

France – Higher education services – Formations aux gestes et soins d'urgence pour le Département de formation médicale

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to encourage individuals who have not had substantial biomedical research experience, or who have the potential to significantly benefit from additional biomedical research experience to pursue further studies or careers in research. To accomplish the stated over-arching goal, this NOFO will support educational activities with a primary focus on: (1) Research Experiences, (2) Curriculum or Methods Development and (3) Outreach. The NCI’s mission is to conduct and support research, training, health information dissemination, and other programs concerning cancer. This funding opportunity seeks to facilitate educational activities that encourage students to become knowledgeable about cancer and available to focus on cancer later in their careers. To promote broad interest in pursuing a career in biomedical research via early intervention strategies, the NCI Youth Enjoy Science (YES) Program will support efforts to create and maintain an institutional program to engage grades 6-12 and/or undergraduate students in cutting edge cancer research experiences. The proposed institutional programs may also provide research experiences for the grade 6-12 teachers and undergraduate faculty members. The goals are to inspire interest in biomedical sciences, help envision research as a career path, and strengthen practical research and career skills. In alignment with these goals, institutions may develop unique programs that capitalize on their research strengths and are responsive to their target populations.

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to accelerate the adoption and validation of molecular/cellular/imaging markers (referred to as "markers" or "biomarkers") and assays for cancer detection, diagnosis, prognosis, monitoring, and prediction of response or resistance to treatment, as well as markers for cancer prevention and control. This NOFO will also support the validation of pharmacodynamic markers and markers of toxicity. Applicants to this NOFO must have an assay(s) whose performance has been analytically validated in specimens similar to those for the intended clinical use of the marker(s) and assay(s). As chemotherapies and/or radiation therapies are increasingly combined with immunotherapies to enhance the durability of anti-cancer responses, assays for measuring multiple markers, including immune markers, can be developed and validated simultaneously. The UH3 mechanism will support the clinical validation of established assays for up to 3 years using specimens from retrospective or prospective clinical trials or studies. This NOFO may be used to validate existing assays for use in other trials, observational studies, or population studies. Efforts to harmonize clinical laboratory tests, including investigation into the performance and reproducibility of assays across multiple clinical laboratories, are also appropriate for this funding opportunity. Projects proposed for this NOFO will require multi-disciplinary interaction and collaboration among scientific investigators, oncologists, statisticians, and clinical laboratory scientists. This NOFO is not intended to support early-stage development of technology or the conduct of clinical trials but is intended for validation of assays to the point where they could be integrated into clinical trials/studies as investigational assays.

Poland – Medical education services – CP-251-131/2026, kompleksowa usługa edukacyjna polegająca na organizacji kursów dla lekarzy uczestniczących w procesie kształcenia specjalizacyjnego, realizowana na potrzeby projektu pn. „Wspieranie kształcenia podyplomowego lekarzy w dziedzinach istotnych z punktu widzenia potrzeb epidemiologiczno-demograficznych Polski (FERS1)”, współfinansowanego ze środków EFS

The purpose of this Notice of Funding Opportunity (NOFO) is to invite research grant applications (R01) for the development and use of current and emerging molecular imaging methods to gain fundamental insights into cancer inflammation in vivo. The motivation for this initiative is that much of current imaging research into the role of inflammation in cancer is largely based on in vitro and ex vivo methods with limited utilization of imaging approaches that could lead to significant new insights relevant to dynamic cancer and inflammation interactions. Utilization of molecular imaging probes in pre-clinical and clinical investigations for precise temporal resolution at the molecular and cellular level are valuable approaches for identification and characterization of in vivo inflammatory cellular physiology in cancers and of molecular changes in response to treatment. This FOA encourages applications that focus on developing integrated imaging approaches to interrogate the role of inflammation in cancer through strong cross-field collaboration between cancer basic science researchers and imaging scientists. These collaborations are expected to advance science and understanding of cancer inflammation interactions.